loadpatents
name:-0.04041314125061
name:-0.027595996856689
name:-0.00043892860412598
Aoki; K. Roger Patent Filings

Aoki; K. Roger

Patent Applications and Registrations

Patent applications and USPTO patent grants for Aoki; K. Roger.The latest application filed is for "reduction of antibody response against botulinum neurotoxin and variants thereof".

Company Profile
0.27.35
  • Aoki; K. Roger - Irvine CA
  • Aoki; K. Roger - Coto de Caza CA US
  • Aoki; K. Roger - Laguna Hills CA
  • Aoki; K. Roger - Laguna Hill CA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Treatment of pain
Grant 9,072,736 - Foster , et al. July 7, 2
2015-07-07
Reduction Of Antibody Response Against Botulinum Neurotoxin And Variants Thereof
App 20130330369 - Atassi; M. Zouhair ;   et al.
2013-12-12
Botulinum toxin treatments
Grant 8,486,886 - Aoki , et al. July 16, 2
2013-07-16
Botulinum Toxin Treatments
App 20120232022 - AOKI; K. Roger ;   et al.
2012-09-13
Post-translational modifications and clostridial neurotoxins
Grant 8,119,767 - Steward , et al. February 21, 2
2012-02-21
Use of the neurotoxic component of a botulinum toxin for treating arthritis
Grant 8,052,980 - Aoki , et al. November 8, 2
2011-11-08
Chimera botulinum toxin type E
Grant 8,017,741 - Fernandez-Salas , et al. September 13, 2
2011-09-13
Nucleic acids encoding chimera botulinum toxin type E
Grant 8,008,465 - Fernandez-Salas , et al. August 30, 2
2011-08-30
Post-translational Modifications And Clostridial Neurotoxins
App 20110046356 - Steward; Lance E. ;   et al.
2011-02-24
Post-translational modifications and Clostridial neurotoxins
Grant 7,893,202 - Steward , et al. February 22, 2
2011-02-22
Post-translation modification and clostridial neurotoxins
Grant 7,888,469 - Steward , et al. February 15, 2
2011-02-15
Post-translational Modification And Clostridial Neurotoxins
App 20100273986 - Steward; Lance E. ;   et al.
2010-10-28
Post-translational Modifications And Clostridial Neurotoxins
App 20100273985 - Steward; Lance E. ;   et al.
2010-10-28
Chimera Botulinum Toxin Type E
App 20100160609 - Fernandez-Salas; Ester ;   et al.
2010-06-24
Chimera Botulinum Toxin Type E
App 20100121042 - Fernandez-Salas; Ester ;   et al.
2010-05-13
Chimera botulinum toxin type E
Grant 7,691,983 - Fernandez-Salas , et al. April 6, 2
2010-04-06
Treatment Of Pain
App 20100034802 - Foster; Keith ;   et al.
2010-02-11
Use of the neurotoxic component of a botulinum toxin for treating arthritis
App 20090318360 - AOKI; K. Roger ;   et al.
2009-12-24
Treatment Of Post-stroke Muscle Pain
App 20090123498 - Aoki; K. Roger ;   et al.
2009-05-14
Methods for treating myofascial pain
Grant 7,501,130 - Aoki , et al. March 10, 2
2009-03-10
Botulinum Toxin Treatments
App 20080213312 - Aoki; K. Roger ;   et al.
2008-09-04
Botulinum Toxin Treatments
App 20080213313 - Aoki; K. Roger ;   et al.
2008-09-04
Neurotoxin Component Treatment For Spasticity
App 20080107762 - Aoki; K. Roger ;   et al.
2008-05-08
Use Of The Neurotoxic Component Of A Botulinum Toxin For Treating A Spastic Muscle
App 20080107763 - Aoki; K. Roger ;   et al.
2008-05-08
Use of the Neurotoxic Component of a Botulinum Toxin
App 20080096822 - Aoki; K. Roger ;   et al.
2008-04-24
Neurotoxic Component Of A Botulinum Toxin
App 20080003318 - Aoki; K. Roger ;   et al.
2008-01-03
Method For Treating Smooth Muscle Disorders With A Neurotoxic Component Of A Botulinum Toxin
App 20080004219 - Aoki; K. Roger ;   et al.
2008-01-03
Use Of The Neurotoxic Component Of A Botulinum Toxin For The Treatment Of Pain Associated With Muscle Activity Or Contracture
App 20070202129 - Aoki; K. Roger ;   et al.
2007-08-30
Post-translational modifications and Clostridial neurotoxins
Grant 7,223,577 - Steward , et al. May 29, 2
2007-05-29
Post-translational modifications and Clostridial neurotoxins
App 20060258843 - Steward; Lance E. ;   et al.
2006-11-16
Methods for treating myofascial pain
App 20060210589 - Aoki; K. Roger ;   et al.
2006-09-21
Methods for treating arthritis pain
Grant 7,091,176 - Aoki , et al. August 15, 2
2006-08-15
Chimera botulinum toxin type E
App 20060039929 - Fernandez-Salas; Ester ;   et al.
2006-02-23
Method for treating secretions and glands using botulinum toxin
Grant 6,974,578 - Aoki , et al. December 13, 2
2005-12-13
Methods for treating pain associated with arthritis
App 20050266029 - Aoki, K. Roger ;   et al.
2005-12-01
Therapeutic use of botulinum toxins types A and B
App 20050129716 - Aoki, K. Roger ;   et al.
2005-06-16
Use of botulinum toxins for treating various disorders and conditions and associated pain
Grant 6,896,886 - Aoki , et al. May 24, 2
2005-05-24
Method for treating pain with botulinum toxin type B
Grant 6,887,476 - Aoki , et al. May 3, 2
2005-05-03
Methods for treating various disorders with a neurotoxic component of a botulinum toxin
App 20050084504 - Aoki, K. Roger ;   et al.
2005-04-21
Method for treating neuromuscular disorders and conditions with botulinum toxin types A and B
Grant 6,872,397 - Aoki , et al. March 29, 2
2005-03-29
Method for treating essential tremor with botulinum toxin type B
Grant 6,861,058 - Aoki , et al. March 1, 2
2005-03-01
Method for treating muscle spasm with botulinum toxin type B
Grant 6,841,156 - Aoki , et al. January 11, 2
2005-01-11
Methods for treating tension headache
Grant 6,776,992 - Aoki , et al. August 17, 2
2004-08-17
Method for treating a cholinergic influenced sweat gland
Grant 6,683,049 - Aoki , et al. January 27, 2
2004-01-27
Use of botulinum toxins for treating various disorders and conditions and associated pain
App 20040013692 - Aoki, K. Roger ;   et al.
2004-01-22
Method for treating tardive dyskinesia with Botulinum toxin type B
Grant 6,645,496 - Aoki , et al. November 11, 2
2003-11-11
Method for treating cervical dystonia with botulinum toxin type B
Grant 6,632,433 - Aoki , et al. October 14, 2
2003-10-14
Methods for treating tension headache
App 20020197279 - Aoki, K. Roger ;   et al.
2002-12-26
Method for treating headache
Grant 6,458,365 - Aoki , et al. October 1, 2
2002-10-01
Treatment of neuromuscular disorders and conditions with different botulinum
App 20020010138 - Aoki, K. Roger ;   et al.
2002-01-24
Use of botulinum toxins for treating various disorders and conditions and associated pain
App 20020006905 - Aoki, K. Roger ;   et al.
2002-01-17
Method for treating muscle spasm with botulinum toxin type B
App 20010053364 - Aoki, K. Roger ;   et al.
2001-12-20
Method for treating cervical dystonia with botulinum toxin type B
App 20010043930 - Aoki, K. Roger ;   et al.
2001-11-22
Method for treating dystonia with botulinum toxin types C to G
Grant 6,319,505 - Aoki , et al. November 20, 2
2001-11-20
Method for treating essential tremor with botulinum toxin type B
App 20010041181 - Aoki, K. Roger ;   et al.
2001-11-15
Method for treating dystonia with botulinum toxin type B
Grant 6,290,961 - Aoki , et al. September 18, 2
2001-09-18
Multiple botulinum toxins for treating neuromuscular disorders and conditions
App 20010021695 - Aoki, K. Roger ;   et al.
2001-09-13
Method for treating tardive dyskinesia with botulinum toxin type B
App 20010018415 - Aoki, K. Roger ;   et al.
2001-08-30
Method for treating neuromuscular disorders and conditions with botulinum toxin types A and B
App 20010012833 - Aoki, K. Roger ;   et al.
2001-08-09

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed